Focus: Hidden - Minnesota

Filters close
Released: 5-Aug-2016 5:05 PM EDT
Tips on Avoiding Illness at Major Events (Like the Olympics) and Projections for a Zika Vaccine
Mayo Clinic

ROCHESTER, Minn. — Zika isn’t the only health concern now that the games have begun in Rio. Massive crowds from around the globe will be at the Olympics, and that means a world-class array of germs will mix with them. Mayo Clinic infectious diseases expert Gregory Poland, M.D., offers several tips for avoiding illness when you are around lots of people, whether at the Olympics, a professional sports event, convention, concert or other major event.

28-Jul-2016 3:05 PM EDT
Insomnia? Oversleeping? Both May Increase Your Risk of Stroke
American Academy of Neurology (AAN)

There is growing evidence that sleep disorders like insomnia and sleep apnea are related to stroke risk and recovery from stroke, according to a recent literature review. The review is published in the August 3, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.

   
2-Aug-2016 12:55 PM EDT
Mayo Researchers Identify Unique Breast Microbiome and Bacterial Differences Between Healthy and Cancerous Tissue
Mayo Clinic

ROCHESTER, Minn. — A team of Mayo Clinic researchers has identified evidence of bacteria in sterilely-obtained breast tissue and found differences between women with and without breast cancer. The findings are published in the Aug. 3 issue of Scientific Reports.

Released: 1-Aug-2016 2:05 PM EDT
Mayo Clinic Monthly News Tips
Mayo Clinic

Mayo Clinic Experts Available for Concussion Discussion As thousands of student athletes across the country prepare for the fall sport season, thousands of parents are concerned about concussions. Up to 4 million sports-related concussions occur in the U.S. each year. And that number may even be higher because many more concussions are not actually diagnosed correctly. Even with all the recent attention on concussions, how much do people really know about how to spot a concussion, what to do about it and how they are treated? Mayo Clinic experts are available to clear up the myths and emphasize the importance of baseline testing during sports physicals.

Released: 29-Jul-2016 10:05 AM EDT
Transit and Training Crucial to Connecting Unemployed with Jobs
University of Minnesota

According to a new University of Minnesota study, the mismatch between unemployed workers and job vacancies is a serious problem in the Twin Cities region and it appears to have worsened since the turn of the millennium. The biggest concentrations of unemployed workers lack fast or frequent transit service to some of the richest concentrations of job vacancies, particularly vacancies in the south and southwest metro.

   
Released: 28-Jul-2016 1:05 PM EDT
Mayo Clinic Studying Genomics of Antiplatelet Heart Medication
Mayo Clinic

ROCHESTER, Minn. — Which antiplatelet medication is best after a coronary stent? The Tailored Antiplatelet Therapy to Lessen Outcomes After Percutaneous Coronary Intervention (TAILOR-PCI) Study examines whether prescribing heart medication based on a patient’s CYP2C19 genotype will help prevent heart attack, stroke, unstable angina, and cardiovascular death in patients who undergo percutaneous coronary intervention (PCI), commonly called angioplasty.

21-Jul-2016 12:05 PM EDT
AAN: Closure Not Recommended for People with Heart Defect and Stroke
American Academy of Neurology (AAN)

MINNEAPOLIS – An updated recommendation from the American Academy of Neurology (AAN) states that catheter-based closure should not be routinely recommended for people who have had a stroke and also have a heart defect called a patent foramen ovale (PFO), a channel between the top two chambers in the heart. The practice advisory, which updates a previous AAN guideline, is published in the July 27, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.

21-Jul-2016 12:05 PM EDT
New Recommendations for Transitioning Youths with Brain Disorders to Adult Care
American Academy of Neurology (AAN)

MINNEAPOLIS – A new consensus statement provides recommendations for transitioning adolescents and young adults with neurologic disorders to adult care. The statement is endorsed by the American Academy of Neurology and created by the Child Neurology Foundation. The research is published in the July 27, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Released: 27-Jul-2016 2:05 PM EDT
Gene Therapy for Metabolic Liver Diseases Shows Promise in Pigs
Mayo Clinic

With a shortage of donor organs, Mayo Clinic is exploring therapeutic strategies for patients with debilitating liver diseases. Researchers are testing a new approach to correct metabolic disorders without a whole organ transplant. Their findings appear in Science Translational Medicine.

Released: 27-Jul-2016 10:10 AM EDT
Updated Testing Guidelines Make More Women Eligible for Herceptin, Yet Benefit Uncertain
Mayo Clinic

ROCHESTER, Minn. — Changes to HER2 testing guidelines for breast cancer in 2013 significantly increased the number of patients who test HER2-positive, according to a new study by Mayo Clinic researchers published in the Journal of Clinical Oncology. Cancers that have an excess of HER2 protein or extra copies of the HER2 gene are called HER2-positive and can be treated with drugs like Herceptin that target HER2. HER2 stands for human epidermal growth factor receptor 2.

Released: 26-Jul-2016 12:05 PM EDT
Count Seals in Antarctica From the Comfort of Your Couch
University of Minnesota College of Science and Engineering

A new citizen science project uses satellite images to get first-ever, comprehensive count of Weddell seals in Antarctica. Counting seals will help scientists better protect and conserve the pristine Ross Sea and wildlife in the area.

Released: 26-Jul-2016 11:05 AM EDT
Stereotactic Radiosurgery May Be Best for Patients with Metastatic Brain Tumors
Mayo Clinic

ROCHESTER, Minn. — Patients with three or fewer metastatic brain tumors who received treatment with stereotactic radiosurgery (SRS) had less cognitive deterioration three months after treatment than patients who received SRS combined with whole brain radiation therapy (WBRT). These findings are according to the results of a federally funded, Mayo Clinic-led, multi-institution research study published today in the Journal of the American Medical Association.

Released: 20-Jul-2016 4:05 PM EDT
Wellness Coaching Can Produce Significant and Long-Term Improvements in Health Behaviors
Mayo Clinic

Making a lifestyle change can be a daunting task, as an overwhelming amount of popular health trends seem unsustainable at best and, at worst, could be dangerous. However, promising results of a study conducted by Mayo Clinic experts suggests that one of these latest trends ─ wellness coaching ─ can produce substantial lifestyle improvements that align with an individual’s personal values and foster confidence to sustain these changes after the program has concluded.

Released: 20-Jul-2016 11:05 AM EDT
Liquid Biopsies Offer Hope for Earlier Treatment, Better Tracking of Ovarian Cancer
Mayo Clinic

Researchers at the Mayo Clinic Center for Individualized Medicine have found a promising new way to monitor and treat recurrence of ovarian cancer — a hard-to-detect disease that claims many lives. New research from George Vasmatzis, Ph.D., of the Department of Laboratory Medicine and Pathology at Mayo Clinic, finds liquid biopsies from blood tests and DNA sequencing can detect a return of ovarian cancer long before a tumor reappears.

15-Jul-2016 1:05 PM EDT
Does Hormone Therapy After Menopause Affect Memory?
American Academy of Neurology (AAN)

Contrary to popular belief, taking estrogen after menopause may not affect the memory and thinking abilities of healthy women no matter when the treatment is started. The research is published in the July 20, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Released: 13-Jul-2016 4:05 PM EDT
Mayo Clinic Scores Perfect 100 on Inaugural Disability Equality Index
Mayo Clinic

Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.

7-Jul-2016 4:05 PM EDT
Alzheimer’s Gene May Show Effects on Brain Starting in Childhood
American Academy of Neurology (AAN)

A gene associated with Alzheimer’s disease and recovery after brain injury may show its effects on the brain and thinking skills as early as childhood, according to a study published in the July 13, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Released: 12-Jul-2016 3:05 PM EDT
Compete in Mayo Clinic’s Second Think Big Challenge for Innovators, Entrepreneurs
Mayo Clinic

The Mayo Clinic Center for Innovation and Mayo Clinic Ventures today announced the second Mayo Clinic Think Big Challenge, a national competition for innovators and entrepreneurs. This year, one business or entrepreneur will earn the opportunity to license Mayo Clinic technology, lead a team and score a $50,000 cash prize.

Released: 12-Jul-2016 2:05 PM EDT
Estrogen Patch in Newly Postmenopausal Women May Reduce Alzheimer’s Risk
Mayo Clinic

Can estrogen preserve brain function and decrease the risk of Alzheimer’s disease when given early in menopause? Newly postmenopausal women who received estrogen via a skin patch had reduced beta-amyloid deposits, the sticky plaques found in the brains of people with Alzheimer’s disease, a Mayo Clinic study published this month in the Journal of Alzheimer’s Disease found. Ultimately, these deposits harm neurons, leading to cognitive problems.

Released: 12-Jul-2016 12:05 PM EDT
Mayo Clinic Researchers Identify Potential Immunotherapy Drug Combination for Targeting Advanced and Metastatic Cancers
Mayo Clinic

A drug combination designed to enhance the immune system’s ability to zero in and attack cancer cells has shown a pronounced therapeutic effect against advanced and metastatic cancers in mice, according to a Mayo Clinic study, published in the July 12 edition of the online journal Oncotarget.

Released: 11-Jul-2016 12:05 PM EDT
Study: Gut Bacteria Can Cause, Predict and Prevent Rheumatoid Arthritis
Mayo Clinic

The bacteria in your gut do more than break down your food. They also can predict susceptibility to rheumatoid arthritis, suggests Veena Taneja, Ph.D., an immunologist at Mayo Clinic’s Center for Individualized Medicine. Dr. Taneja recently published two studies — one in Genome Medicine and one in Arthritis and Rheumatology — connecting the dots between gut microbiota and rheumatoid arthritis.

Released: 7-Jul-2016 4:05 PM EDT
2016 AAN Neuro Film Festival Winners Announced
American Academy of Neurology (AAN)

The American Academy of Neurology (AAN) is pleased to announce the winning entries to the 2016 Neuro Film Festival. The Neuro Film Festival is an annual contest to help raise awareness about why more research is needed to cure brain diseases such as Alzheimer’s disease, stroke, epilepsy, Parkinson’s disease, multiple sclerosis and others.

   
Released: 7-Jul-2016 4:05 PM EDT
American Academy of Neurology, American Brain Foundation and Muscular Dystrophy Association Offer New Research Award
American Academy of Neurology (AAN)

The American Academy of Neurology (AAN), the American Brain Foundation (ABF) and the Muscular Dystrophy Association (MDA) have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.

6-Jul-2016 11:05 AM EDT
Athletes May Have White Matter Brain Changes Six Months After a Concussion
American Academy of Neurology (AAN)

New research finds white matter changes in the brains of athletes six months after a concussion. The study will be presented at the Sports Concussion Conference in Chicago, July 8-10, hosted by the American Academy of Neurology, the world’s leading authority on the diagnosis and management of sports-related concussion. The conference brings together leading experts in the field to present and discuss the latest scientific advances in diagnosing and treating sports-related concussion.

30-Jun-2016 2:00 PM EDT
Genetic Risk Factors for Alzheimer’s Disease May Be Detectable Even in Young Adults
American Academy of Neurology (AAN)

MINNEAPOLIS – New research shows that a genetic risk score may detect those at higher risk for Alzheimer’s disease long before symptoms appear—even possibly in healthy young adults, according to a study published in the July 6, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Released: 5-Jul-2016 3:05 PM EDT
Mayo Clinic Monthly News Tips
Mayo Clinic

Mayo Clinic Monthly News Tips for July of 2016

Released: 30-Jun-2016 3:05 PM EDT
U of M Astronomers Help Citizen Scientists Discover Rare Galaxy Cluster
University of Minnesota College of Science and Engineering

Discovery 1.2 billion light years away could provide new clues to how the Universe works

23-Jun-2016 5:05 PM EDT
Stem Cell Treatment for Lou Gehrig’s Disease May Be Safe
American Academy of Neurology (AAN)

A phase II clinical trial in people with amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, suggests that transplanting human stem cells into the spinal cord may be done safely. The research is published in the June 29, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. While the study was not designed to determine whether the treatment was effective, researchers noted that it did not slow down the progression of the disease.

Released: 29-Jun-2016 11:05 AM EDT
Everolimus R-CHOP Combination Safe for Treating Diffuse Large B-Cell Lymphoma
Mayo Clinic

ROCHESTER, Minn. — The targeted therapy everolimus may be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma according to the results of a pilot study by Mayo Clinic researchers published in the Lancet Haematology. R-CHOP is a combination of drugs used to treat lymphoma. The combination includes rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone.

Released: 28-Jun-2016 10:05 PM EDT
Coach Pat Summitt Remembered for Fight Against Alzheimer’s Disease
Mayo Clinic

After legendary basketball coach Pat Summitt was diagnosed with early-onset Alzheimer’s disease at Mayo Clinic in 2011, the winningest coach in NCAA Division 1 history went public with her battle against the disease. Today, Mayo Clinic mourns the loss of Coach Summitt and extends condolences to her family.

Released: 27-Jun-2016 10:05 AM EDT
Transplant Genomics Enters Collaboration with Mayo Clinic
Mayo Clinic

Transplant Genomics Inc.® (TGI) is collaborating with the Mayo Clinic Center for Individualized Medicine to develop, validate and commercialize diagnostic tests enabling personalized immunosuppression for solid organ transplant recipients.

22-Jun-2016 10:00 AM EDT
Electronic Medical Practice Environment Can Lead to Physician Burnout
Mayo Clinic

The growth and evolution of the electronic environment in health care is taking a toll on U.S. physicians. That’s according to a national study of physicians led by Mayo Clinic which shows the use of electronic health records and computerized physician order entry leads to lower physician satisfaction and higher rates of professional burnout. The findings appear in Mayo Clinic Proceedings.

Released: 24-Jun-2016 11:05 AM EDT
Regenerative Medicine Offering New Treatment for Bronchopleural Fistulas
Mayo Clinic

For the first time in human application, Mayo Clinic researchers successfully closed an open wound on the upper chest caused by postoperative complications of lung removal. The protocol and approach were based on an ongoing trial investigating this method to treat anal fistulas in Crohn’s disease.

Released: 23-Jun-2016 11:05 AM EDT
Mayo Clinic to Unveil New, Smaller MRI Scanner Developed by GE Researchers
Mayo Clinic

On June 28, Mayo Clinic will unveil a new, one-of-a-kind, compact 3T magnetic resonance imaging (MRI) scanner developed in collaboration with General Electric’s (GE) Global Research Center to an invitation-only audience.

16-Jun-2016 1:05 PM EDT
Is Huntington’s Disease More Common Than We Thought?
American Academy of Neurology (AAN)

More people may have the potential to develop Huntington’s disease than previously thought, according to a study published in the June 22, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. But the increase comes in the percentage of people who have a lower risk of developing the hereditary disease, which causes uncontrolled movements, loss of intellectual abilities, emotional problems and eventually death.

Released: 22-Jun-2016 12:05 PM EDT
National Institutes of Health Chooses Mayo Clinic for Biobank, but What Is a Biobank?
Mayo Clinic

On May 26, the National Institutes of Health (NIH) awarded Mayo Clinic $142 million over five years to serve as home for the 1-million-person Precision Medicine Initiative® (PMI) biobank.

Released: 21-Jun-2016 2:05 PM EDT
Mayo Clinic Assists Google in Providing Quick, Accurate Symptom and Related Condition Information
Mayo Clinic

When people seek information on health-related symptoms, many turn to the internet, and Google in particular, as the first stop. Now, when consumers access Google’s mobile search for information about certain symptoms, they will get facts on relevant related medical conditions up front on their smartphone or other mobile device.

Released: 21-Jun-2016 12:05 PM EDT
Mayo Clinic Children’s Center Ranks Among the Nation’s Best
Mayo Clinic

Mayo Clinic Children’s Center is ranked again as one of the top performing children’s hospitals in Minnesota, the Dakotas and Iowa area on U.S. News & World Report’s 2016–2017 Best Children’s Hospitals rankings.

21-Jun-2016 4:00 AM EDT
Mayo Clinic Introduces Precision Medicine in Psychiatry
Mayo Clinic

Mayo Clinic highlights the potential merits of using precision medicine in prescribing antidepressants. Details appear in the current issue of Mayo Clinic Proceedings. Eleven percent of Americans 12 years and older have been prescribed antidepressant medication, according to CDC data from 2005–2008.

Released: 20-Jun-2016 2:05 PM EDT
Mayo Clinic Study Shows Increase in Parkinson’s Disease Over 30 Years
Mayo Clinic

ROCHESTER, Minn. — The incidence of Parkinson’s disease and parkinsonism increased significantly in 30 years from 1976 to 2005, Mayo Clinic researchers reported today in a study in JAMA Neurology. This trend was noted in particular for men age 70 and older. According to the researchers, this is the first study to suggest such an increasing trend.

Released: 17-Jun-2016 1:05 PM EDT
Task Force Cancer Screening Recommendations Now Include Stool DNA Test
Mayo Clinic

ROCHESTER, Minn. — The United States Preventive Services Task Force has issued its final colorectal cancer screening recommendations for 2016. The Task Force assigns an overall “A” grade to colorectal cancer (CRC) screening in people ages 50-75, and fully recommends several screening exams that now includes Cologuard, the stool DNA test codeveloped by Mayo Clinic and Exact Sciences.

Released: 16-Jun-2016 1:05 PM EDT
Having a Relative with Epilepsy May Increase Your Risk of Being Diagnosed with Autism
American Academy of Neurology (AAN)

Having a first-degree relative with epilepsy may increase a person’s risk of being diagnosed with autism, according to a study published in the June 15, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Released: 14-Jun-2016 2:05 PM EDT
Mayo Clinic Researchers Develop Accurate Way to Measure Growth Factor Linked to Aging
Mayo Clinic

Researchers at Mayo Clinic have developed an accurate way to measure a circulating factor, called GDF11, to better understand its potential impact on the aging process. They found that GDF11 levels do not decline with chronological age, but are associated with signs of advanced biological age, including chronic disease, frailty and greater operative risk in older adults with cardiovascular disease. Results appear today in Cell Metabolism.

Released: 14-Jun-2016 2:05 PM EDT
Mayo Clinic Researchers Link Specific Enzyme to Process of Metabolic Dysfunction in Aging
Mayo Clinic

Researchers at Mayo Clinic have identified the enzyme, called CD38, that is responsible for the decrease in nicotinamide adenine dinucleotide (NAD) during aging, a process that is associated with age-related metabolic decline. Results demonstrated an increase in the presence of CD38 with aging in both mice and humans. The results appear today in Cell Metabolism.

Released: 14-Jun-2016 9:00 AM EDT
Mayo Clinic Neuropathologist Awarded International Professional Society’s Highest Honor
Mayo Clinic

Dennis W. Dickson, M.D., a neuropathologist at Mayo Clinic’s campus in Florida, will receive the highest honor bestowed by the American Association of Neuropathologists (AANP), an international society of physicians and scientists who study, diagnose and treat diseases related to the brain, nerves and muscles.

2-Jun-2016 11:05 AM EDT
New Drug to Prevent Migraine May Start Working in Days
American Academy of Neurology (AAN)

A new drug to prevent migraine was associated with fewer headache hours for people with chronic migraine within three to seven days after the first injection, according to a study published in the June 8, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. Chronic migraine is defined as headaches occurring at least 15 days per month. Study participants had migraine attacks for an average of 20 years prior to treatment.

Released: 7-Jun-2016 11:05 PM EDT
Mayo Clinic to Grow Rochester Research Footprint by 2 Million Square Feet to Fuel First Urban Bioresearch Campus
Mayo Clinic

Mayo Clinic announced the next major step in realizing Destination Medical Center’s (DMC) vision of creating Discovery Square, a first-of-its-kind urban bioresearch campus that brings together renowned physicians, researchers, scientists and entrepreneurs to address unmet patient needs in an ultramodern setting for science innovation.

Released: 7-Jun-2016 10:05 AM EDT
Mayo Clinic First to Implant Device to Solve Fecal Incontinence
Mayo Clinic

A clinical team on Mayo Clinic’s Florida campus is the first to offer four patients with long-term fecal incontinence a new and potentially long-lasting treatment — a small band of interlinked magnetic titanium beads on a titanium string that successfully mimics the function of the anal sphincter.

2-Jun-2016 3:00 PM EDT
Intensive Treatment of Glucose Levels Can Lead to Serious Complications
Mayo Clinic

With a more-is-better mindset common in society, frequent commercials encouraging checks of glycated hemoglobin (HbA1C) levels, and ads for new diabetes medications to lower HbA1C in adults with Type 2 diabetes, Mayo Clinic researchers were not too surprised to find overtesting occurring.



close
2.05021